Plasma lipids in Nigerians with systemic arterial hypertension

References 

1. Integrated management of cardiovascular risk: report of a WHO meeting. Geneva. 9–12 July 2002. NLM classification: WG 166.
2. Kannel WB. Blood pressure as a cardiovascular risk factor: prevention and treatment. JAMA. 1996;275:1571–1576
   • MEDLINE
3. Marmot MG, Mann JI, Meade TW. Epidemiology and prevention of ischaemic heart disease. In:  Ledingham JGG,  Warrel DA editor. Concise Oxford Textbook of Medicine. 1st ed.. Oxford: Oxford University Press; 2000;p. 56–63
4. Non Communicable Diseases (NCD) in Nigeria—Final Report of a National Survey (Federal Ministry of Health National Expert Committee on NCD). 1977;
5. Perloff D, Grim C, Flack J, et al. Human blood pressure determination by sphygmomanometry. Circulation. 1993;88:2460–2467
   • MEDLINE
6. Friedwald WT, Levy RI, Friedrickson DS. Estimation of the concentration of low density lipoprotein cholesterol in plasma without use of preparative ultracentrifugation. Clin Chem. 1972;18:499–502
   • MEDLINE
7. 1999 World Health Organisation/International Society of Hypertension guidelines for the management of hypertension. Blood Press. 1999;8(suppl 1):3–43
   • MEDLINE
   • CrossRef
8. National Cholesterol Education Program. Third Report of the Expert Panel on the Detection, Evaluation and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) (National Heart Lung and Blood Institute). In: 2002;p. 3163–3184National Institutes of Health Publication no. 02–5215
9. Yusuf S, Hawken S, Ounpuu S INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART Study): case-control study. Lancet. 2004;364:937–952
   • Abstract
   • Full Text
   • Full-Text PDF (257 KB)
   • CrossRef
10. Taylor OG, Oyediran ABOO, Bamgboye AE, Afolabi BM, Osuntokun BO. Profile of some risk factors for coronary heart disease in a developing country: Nigeria. Afr J Med Med Sci. 1996;25:341–346
    • MEDLINE
11. Opadijo OG, Akande AA, Jimoh AK. Prevalence of coronary heart disease risk factors in Nigerians with systemic hypertension. Afr J Med Med Sci. 2004;33:121–125
    • MEDLINE
12. Khan MG. Beta blockers. In:  Khan MG editors. Encyclopedia of Heart Diseases. Amsterdam: Elsevier Academic Press; 2006;p. 159–167
13. Esler M, Straznicky N, Eikelis N, Masus K, Lambert G, Lambert E. Mechanism of sympathetic activation in obesity related hypertension. Hypertension. 2006;48:787–796
    • CrossRef
14. Khan MG. Hypertension. In:  Khan MG editors. Encyclopedia of Heart Diseases. Amsterdam: Elsevier Academic Press; 2006;p. 469–491
15. Obeka NC, Okeahialam BN. Influence of short term thiazide diuretic anti-hypertensive therapy on serum uric acid and lipid profile in hypertensive adult Nigerians. Trop Cardiol. 2006;32:34–38
16. Farmer JA, Gotto AM. Dyslipidaemia and other risk factors for coronary artery disease. In:  Braunwald E editors. Heart Diseases. A Textbook of Cardiovascular Medicine. 5th ed.. Philadelphia: W.B. Saunders; 1997;p. 1126–1160
17. Okeahialam BN, Osunkwo DA, Isichei CO. Atherogenic burden of hypertensive, diabetic and hypertensive-diabetic patients seen in Jos. J Med Trop. 2003;5:50–55
18. Miller NE, Forde OH, Tella DS, Mjos OD. The Tromso Heart Study (High density lipoprotein and coronary heart disease. A prospective case-controlled study). Lancet. 1977;1:965–968
    • MEDLINE
19. Adedeji OO. The plasma lipid concentration in healthy Nigerians. Trop Geogr Med. 1994;46:23–26
    • MEDLINE
20. Kris-Etherton PM, Hilpert KF, Krauss RM. Nutrition. In:  Wong ND,  Black HR,  Gardin JM editor. Preventive Cardiology: A Practical Approach. 2nd ed.. New York: McGraw-Hill Medical Publishing Division; 2005;p. 256–295
21. Wahdan MH. The epidemiological transition. Eastern Med Hlth J. 1996;2:8–20